JUPITER, Fla., May 7, 2013 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the industrial enzyme, bioenergy, and biopharmaceutical industries, announced today that Danai Brooks will join the Company as Executive Vice President and Chief Operating Officer in June. Brooks joins Dyadic from J.P. Morgan where he served as a Vice President in the firm's Investment Bank.
"Danai has significant financial and operational experience in the renewable energy and bio-based chemical space, and will be a tremendous asset to Dyadic," said Mark Emalfarb , Dyadic's President and Chief Executive Officer. "As EVP and COO, Danai will play a key role in driving our business development and licensing efforts, as well as corporate strategic planning and operational improvements across the globe."
"As a long-time advisor to Dyadic, I am intimately familiar with the Company and thrilled to have the opportunity to join the team," said Brooks. "Dyadic continues to compete with larger industrial enzyme companies using its game-changing C1 enzyme expression platform. Together, we will continue to build commercial momentum through enzyme sales and strategic partnerships across a wide range of sectors including cellulosic biofuels, biopharmaceuticals and industrial applications. We look forward to introducing new C1-based products to the many industries and companies that can benefit from C1's ability to produce enzymes and other proteins with class leading performance."
While at J.P. Morgan, Brooks advised clients across a broad spectrum of sectors, including chemica
|SOURCE Dyadic International, Inc.|
Copyright©2012 PR Newswire.
All rights reserved